This is a good sign - SSH is expanding. With any luck, some of those new Sunshine Heart positions will be dedicated to increasing the pace of enrollment in the ongoing FDA trial - which is currently the cause of a lot of malaise among investors.
And maybe they'll hire a marketing guru who can help spread the word about C-Pulse to patients and cardiologists alike.